标题
Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models
作者
关键词
Glioblastoma, Brain tumour, PI3K, Proliferation, Dactolisib, BEZ235, Patient-derived xenograft
出版物
BMC CANCER
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-08-19
DOI
10.1186/s12885-016-2712-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dual Phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer
- (2015) Yu-Hsuan Chen et al. CANCER LETTERS
- NVP-BEZ235, a novel dual PI3K–mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells
- (2015) Zhiyun Yu et al. CANCER LETTERS
- Development of Resistance to EGFR-Targeted Therapy in Malignant Glioma Can Occur through EGFR-Dependent and -Independent Mechanisms
- (2015) S. Klingler et al. CANCER RESEARCH
- Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models
- (2015) Stefanie Schrauwen et al. GYNECOLOGIC ONCOLOGY
- A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors
- (2015) Johanna C. Bendell et al. INVESTIGATIONAL NEW DRUGS
- Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide
- (2015) Minh Thi Tieu et al. JOURNAL OF NEURO-ONCOLOGY
- Efficacy of dual PI-3K and mTOR inhibitors in vitro and in vivo in acute lymphoblastic leukemia
- (2015) Jacky Wong et al. Oncotarget
- The mechanism of chemoresistance against tyrosine kinase inhibitors in malignant glioma
- (2014) Mitsutoshi Nakada et al. Brain Tumor Pathology
- MRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activity
- (2014) J Cebulla et al. BRITISH JOURNAL OF CANCER
- Combine MEK inhibition with PI3K/mTOR inhibition exert inhibitory tumor growth effect on KRAS and PIK3CA mutation CRC xenografts due to reduced expression of VEGF and matrix metallopeptidase-9
- (2014) Jifu E et al. TUMOR BIOLOGY
- Androgen receptor signaling regulates growth of glioblastoma multiforme in men
- (2014) Xiaoming Yu et al. TUMOR BIOLOGY
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma
- (2013) Carlos Rodrigo Gil del Alcazar et al. CLINICAL CANCER RESEARCH
- Extended treatment with selective phosphatidylinositol 3-kinase and mTOR inhibitors has effects on metabolism, growth, behaviour and bone strength
- (2013) Greg C. Smith et al. FEBS Journal
- Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation
- (2013) Y. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Development of PI3K inhibitors: lessons learned from early clinical trials
- (2013) Jordi Rodon et al. Nature Reviews Clinical Oncology
- Why Can’t Rodents Vomit? A Comparative Behavioral, Anatomical, and Physiological Study
- (2013) Charles C. Horn et al. PLoS One
- Targeting PI3K in Cancer: Any Good News?
- (2013) Miriam Martini et al. Frontiers in Oncology
- Current clinical development of PI3K pathway inhibitors in glioblastoma
- (2012) P. Y. Wen et al. NEURO-ONCOLOGY
- Recent Advances in Therapy for Glioblastoma
- (2010) Jennifer Clarke et al. ARCHIVES OF NEUROLOGY
- A reproducible brain tumour model established from human glioblastoma biopsies
- (2010) Jian Wang et al. BMC CANCER
- Signal transduction therapy of cancer
- (2010) Alexander Levitzki et al. MOLECULAR ASPECTS OF MEDICINE
- Insulin signaling meets mitochondria in metabolism
- (2010) Zhiyong Cheng et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts
- (2009) P Cao et al. BRITISH JOURNAL OF CANCER
- Cancer therapy targeted at cellular signal transduction mechanisms: Strategies, clinical results, and unresolved issues
- (2009) Thoralf Christoffersen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas
- (2009) T.-J. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- The current state of serum biomarkers of hepatotoxicity
- (2007) Josef Ozer et al. TOXICOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search